Nissan (NISA) - Total Assets
Based on the latest financial reports, Nissan (NISA) holds total assets worth ILA654.44 Million ILA (≈ $1.75 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See NISA total equity for net asset value and shareholders' equity analysis.
Nissan - Total Assets Trend (2007–2024)
This chart illustrates how Nissan's total assets have evolved over time, based on quarterly financial data.
Nissan - Asset Composition Analysis
Current Asset Composition (December 2024)
Nissan's total assets of ILA654.44 Million consist of 39.1% current assets and 60.9% non-current assets.
| Asset Category | Amount (ILA) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ILA0.00 | 2.2% |
| Accounts Receivable | ILA84.99 Million | 12.0% |
| Inventory | ILA169.25 Million | 23.9% |
| Property, Plant & Equipment | ILA0.00 | 0.0% |
| Intangible Assets | ILA941.00K | 0.1% |
| Goodwill | ILA35.24 Million | 5.0% |
Asset Composition Trend (2007–2024)
This chart illustrates how Nissan's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Nissan (NISA) market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Nissan's current assets represent 39.1% of total assets in 2024, an increase from 0.0% in 2007.
- Cash Position: Cash and equivalents constituted 2.2% of total assets in 2024, up from 1.2% in 2007.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 4.0% of total assets, a decrease from 25.0% in 2007.
- Asset Diversification: The largest asset category is inventory at 23.9% of total assets.
Nissan Competitors by Total Assets
Key competitors of Nissan based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Pulse Biosciences Inc
NASDAQ:PLSE
|
USA | $81.62 Million |
|
Caina Technology Co. Ltd.
SHE:301122
|
China | CN¥2.24 Billion |
|
SWS Hemodialysis Care Co. Ltd. A
SHG:688410
|
China | CN¥2.06 Billion |
|
Guangzhou Jet Bio-Filtration Co Ltd
SHG:688026
|
China | CN¥1.75 Billion |
|
Safe Orthopaedics SA
PA:ALSAF
|
France | €7.94 Million |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.33 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$279.25 Million |
|
SDI Ltd
AU:SDI
|
Australia | AU$135.84 Million |
Nissan - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.93 | 1.22 | 1.00 |
| Quick Ratio | 0.49 | 0.55 | 0.71 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ILA-18.30 Million | ILA50.56 Million | ILA663.00K |
Nissan - Advanced Valuation Insights
This section examines the relationship between Nissan's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.44 |
| Latest Market Cap to Assets Ratio | 0.03 |
| Asset Growth Rate (YoY) | 0.3% |
| Total Assets | ILA707.88 Million |
| Market Capitalization | $18.82 Million USD |
Valuation Analysis
Below Book Valuation: The market values Nissan's assets below their book value (0.03x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Nissan's assets grew by 0.3% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Nissan (2007–2024)
The table below shows the annual total assets of Nissan from 2007 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ILA707.88 Million ≈ $1.90 Million |
+0.27% |
| 2023-12-31 | ILA705.98 Million ≈ $1.89 Million |
-4.09% |
| 2022-12-31 | ILA736.12 Million ≈ $1.97 Million |
+0.83% |
| 2021-12-31 | ILA730.04 Million ≈ $1.96 Million |
+4.22% |
| 2020-12-31 | ILA700.51 Million ≈ $1.88 Million |
+1.49% |
| 2019-12-31 | ILA690.22 Million ≈ $1.85 Million |
-6.20% |
| 2018-12-31 | ILA735.85 Million ≈ $1.97 Million |
+5.32% |
| 2017-12-31 | ILA698.68 Million ≈ $1.87 Million |
-8.91% |
| 2016-12-31 | ILA767.04 Million ≈ $2.06 Million |
+5.50% |
| 2015-12-31 | ILA727.03 Million ≈ $1.95 Million |
+41.10% |
| 2014-12-31 | ILA515.26 Million ≈ $1.38 Million |
+6.47% |
| 2013-12-31 | ILA483.96 Million ≈ $1.30 Million |
+5.63% |
| 2012-12-31 | ILA458.14 Million ≈ $1.23 Million |
-5.18% |
| 2011-12-31 | ILA483.19 Million ≈ $1.30 Million |
+10.51% |
| 2010-12-31 | ILA437.24 Million ≈ $1.17 Million |
-9.16% |
| 2009-12-31 | ILA481.36 Million ≈ $1.29 Million |
+2.94% |
| 2008-12-31 | ILA467.61 Million ≈ $1.25 Million |
-2.69% |
| 2007-12-31 | ILA480.51 Million ≈ $1.29 Million |
-- |
About Nissan
Nissan Medical Industries Ltd manufactures and markets spunlace non-woven fabrics in the United States, Canada, Europe, the Far East, Israel, and internationally. The company's products are used in reusable and consumable consumer products, medical products, automotive, infrastructure, hygienic, and other industries. It sells its products through its sales agents. Nissan Medical Industries Ltd wa… Read more